Isoniazid preventive therapy has been recommended for all HIV patients with latent TB in Nigeria, but there is no little or no monitoring of adverse drug reactions. Therefore the need to monitor the adverse effect of this drug which is used concomitantly with other drugs in people living with HIV and to ensure that it is safe for use.